Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Covington
AstraZeneca
Healthtrust
Citi
Deloitte
US Army
Novartis
Fish and Richardson
Daiichi Sankyo

Generated: December 11, 2017

DrugPatentWatch Database Preview

Details for Patent: 6,352,717

« Back to Dashboard

Which drugs does patent 6,352,717 protect, and when does it expire?


Patent 6,352,717 protects FORTOVASE and is included in one NDA.

Protection for FORTOVASE has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has thirty-seven patent family members in thirty-four countries.

Summary for Patent: 6,352,717

Title: Process for encapsulating shear sensitive fill masses into capsules and capsules containing shear sensitive fill masses
Abstract:The present invention provides a process for encapsulating a shear sensitive fill mass which contains a pharmaceutical active agent or nutrient, characterized in that said fill mass is heated and subsequently cooled, prior to the encapsulation. The invention also provides capsules comprising shear sensitive fill material obtained by the said process which have a high and constant dissolution rate.
Inventor(s): Alex; Rainer (Weil am Rhein, DE), Gerhards; Jurgen (Arlesheim, CH), Kraemer-Pittrof; Ingeborg (Rheinfelden, DE), Oeschger; Richard (Rheinsulz, CH), Rades; Thomas (Dunedin, NZ)
Assignee: Hoffman-La Roche Inc. (Nutley, NJ)
Application Number:09/440,731
Patent Claim Types:
see list of patent claims
Dosage form; Process; Formulation;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Patented / Exclusive Use
Hoffmann La RocheFORTOVASEsaquinavirCAPSULE;ORAL020828-001Nov 7, 1997DISCNYesNo► Subscribe► Subscribe► SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: 6,352,717

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
98121831Nov 17, 1998

International Patent Family for Patent: 6,352,717

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Turkey200101358► Subscribe
Slovenia1131037► Subscribe
Russian Federation2219911► Subscribe
Portugal1131037► Subscribe
Poland190382► Subscribe
Poland348350► Subscribe
Peru12402000► Subscribe
New Zealand511663► Subscribe
Norway20012384► Subscribe
Malaysia120081► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
Queensland Health
Cerilliant
Healthtrust
Citi
Chubb
Federal Trade Commission
Cipla
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot